Dx & Vx Co., Ltd.

Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.

180400 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 금천구 디지털로 173, 금천구
Website:: https://www.dxvx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dx & Vx Co., Ltd. is a global bio-healthcare company focused on developing innovative diagnostics (Dx) and vaccines (Vx). The company leverages proprietary technologies, including a platform for long-term, room-temperature storage of mRNA vaccines and a universal Next-Generation Sequencing (NGS) platform. Its R&D pipeline targets infectious diseases, immuno-oncology, obesity, and eye diseases. In addition to its drug development, Dx & Vx provides a comprehensive suite of services to the life sciences industry, including contract development (CDO), manufacturing (CMO), sales (CSO), and companion diagnostics (CDx) development. The company also develops microbiome-based products and offers medical data services.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Dx & Vx Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dx & Vx Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Dx & Vx Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Genome&Company Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.	South Korea	314130
Genomictree Inc. Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.	South Korea	228760
Genomtec S.A. Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.	Poland	GMT
GENOTECH CORP. A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.	South Korea	066830
Gentian Diagnostics ASA Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.	Norway	GENT
GI Innovation Inc. Develops fusion protein biologics for oncology, allergic, and metabolic diseases.	South Korea	358570
GlaxoSmithKline PLC A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.	United Kingdom	GSK
GL Pharm Tech Corp. Develops improved drugs and generics, and licenses proprietary drug formulation technologies.	South Korea	204840
GNI Group Ltd. Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.	Japan	2160
Goodwill Pharma Plc Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.	Hungary	GWPH